| 000 | 01689cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030657.0 | ||
| 008 | 120923s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.08.Ph.D.2012.Mo.P | ||
| 100 | 0 | _aMohamed Aly Abdelaziz Aly Eldegwy | |
| 245 | 1 | 2 |
_aA pharmaceutical study on certain anti - rheumatic drugs / _cMohamed Aly Abdelaziz Aly Eldegwy ; Supervised Saadia A. Tayel , Mohamed A. Elnabarawi , Randa Tag Abdelrehem |
| 246 | 1 | 5 | _aدراسة صيدلية لبعض المضادات الروماتزمية |
| 260 |
_aCairo : _bMohamed Aly Abdelaziz Aly Eldegwy , _c2012 |
||
| 300 |
_a283P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aNovel drug delivery systems can provide improved or unique clinical benefits such as improvement of patient compliance , reduction of adverse effects , allowing patients to receive medications as outpatients , reduction in the overall use of medicinal resources and economic benefits . As life expectancy increased , the elderly and children constitute large portion of the worldwide population today | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAceclofenac | |
| 653 | 4 | _aDiclofenac potassium | |
| 653 | 4 | _aODT | |
| 700 | 0 |
_aMohamed Ahmed Elnabarawi , _eSupervisor |
|
| 700 | 0 |
_aRanda Tag Abdelrehem , _eSupervisor |
|
| 700 | 0 |
_aSaadia Ahmed Tayel , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c39632 _d39632 |
||